Florence Pasquier

Mar 7, 2024 | touchoncology.com | Florence Pasquier |Stephane de Botton

Leukaemia Read Time: 14 mins Copy Link Published Online: Mar 7th 2024 touchREVIEWS in Oncology & Haematology. 2024;20(1):1–5:Online ahead of journal publication Authors: Florence Pasquier, Stéphane De Botton Quick Links: Overview Management of patients with relapsed or refractory (R/R) acute myeloid leukaemia (AML) is challenging, as their prognosis remains poor with conventional therapies, underlining the need for the development of new drugs.